Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001085146-25-005169·BIOMARIN PHARMACEUTICAL INC
Schedule 13G ownership disclosure
BioMarin Pharmaceutical Inc
COM · CUSIP: 09061G101
Event date: 2025-06-30
- Filing-level shares
- 15,795,383
- Percent of class
- 8.24%
- PRIMECAP MANAGEMENT CO/CA/
Shares: 15,795,383 · Class: 8.24%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-25-005169
- Form type
- SCHEDULE 13G/A
- Filer
- BIOMARIN PHARMACEUTICAL INC
- CIK
- CIK 1048477
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership